Skip to content

Clinical trials

Phase 2 Lupus Nephritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Nephritis Phase: Phase 2 Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20082
20101
20111
20121
20131
20141
20153
20162
20182
20191
20201
20212
20224
20232
20242
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated11
Recruiting7
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)4
Alexion Pharmaceuticals, Inc.2
Biogen2
Boehringer Ingelheim2
Hoffmann-La Roche2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
Akebia Therapeutics1
Amgen1
Apellis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Nephritis34
Lupus Erythematosus, Systemic10
Glomerulonephritis, IGA5
Glomerulonephritis4
Glomerulonephritis, Membranous3
Autoimmune Diseases2
Glomerulonephritis, Membranoproliferative2
Kidney Diseases2
Nephritis2
Proteinuria2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.